Impact of recombinant activated factor VII on health-related quality of life after intracerebral hemorrhage

Cerebrovascular Diseases

Volumn 24, Issue 2-3, 2007, Pages 219-225

  Diringer, Michael N ^a   Ferran, Jean Marc ^b   Broderick, Joseph ^c   Davis, Stephen ^d   Mayer, Stephan A ^e   Steiner, Thorsten ^f   Brun, Nikolai C ^b   Skolnick, Brett E ^g   Christensen, Michael C ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NOVO NORDISK A S   (Denmark)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e Columbia University College of Physicians and Surgeons ^*  (United States)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g NOVO NORDISK INC   (United States)

Author keywords

Intracerebral hemorrhage; Quality of life; Recombinant factor VIIa

Indexed keywords

PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

AGED; ALGORITHM; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLICATION; QUALITY OF LIFE; RANKIN SCALE; VISUAL ANALOG SCALE;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ALGORITHMS; ASIA; AUSTRALIA; CEREBRAL HEMORRHAGE; COAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EUROPE; FACTOR VIIA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; PERCEPTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RECOMBINANT PROTEINS; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES;

EID: 34548065713     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104481     Document Type: Article

References (25)

1. Straten van A, Reitsma JB, Limburg M, Bos van den GAM: Impact of stroke type on survival and functional health. Cerebrovasc Dis 2001;12:27-33.
2. Schlote A, Richter M, Frank B, Wallesch CW: A longitudinal study of health-related quality of life of first stroke survivors' close relatives. Cerebrovasc Dis 2006;22:137-142.
3. Visser-Meily A, Post M, Schepers V, Lindeman E: Spouses' quality of life 1 year after stroke: prediction at the start of clinical rehabilitation. Cerebrovasc Dis 2005;20:443-448.
4. Broderick J, Brott T, Tomsick T, Miller R, Huster G: Intracerebral hemorrhage is more than twice as common as subarachnoid hemorrhage. J Neurosurg 1993;78:188-191.
5. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005;352:777-785.
6. Dorman PJ, Waddell F, Slattery J, Dennis M, Sandercock P: Is the EuroQol a valid measure of health-related quality of life after stroke? Stroke 1997;28:1876-1882.
7. Brooks R, Rabin R, de Charro F (eds): The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective: Evidence from the EuroHRQL BIO MED Research Programme. Dordrecht, Kluwer Academic, 2003.
8. Shaw JW, Johnson JA, Coons SJ: US valuation of the EQ-5D health states: development and testing of the D2 valuation model (2005). Med Care 2005;43:203-220.
9. Greiner W, Claes C, Busschbach JJ, Graf von der Schulenburg JM: Validating the EQ-5D with time-trade off for the German population. Eur J Health Econ 2004, E-pub ahead of print.
10. Samsa GP, Matchar DB, Goldstein L, Bonito A, Duncan PW, Lipscomb J, Enarson C, Witter D, Venus P, Paul JE, Weinberger M: Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke. Am Heart J 1998;136:703-713.
11. Gage BF, Cardinali AB, Owens DK: The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. Arch Intern Med 1996;156:1829-1836.
12. Stahl JE, Furie KL, Gleason S, Gazelle GS: Stroke: effect of implementing an evaluation and treatment protocol compliant with NINDS recommendations. Radiology 2003;228:659-668.
13. Solomon NA, Glick HA, Russo CJ, Lee J, Schulman KA: Patient preferences for stroke outcomes. Stroke 1994;25:1721-1725.
14. McCullagh P: Regression models for ordinal data. J R Stat Soc 1980B;43:109-142.
15. Luo N, Johnson JA, Shaw JW, Feeny D, Coons SJ: Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med Care 2005;43:1078-1086.
16. Samsa G, Edelman D, Rothman ML, Williams GR, Lipscomb J, Matchar D: Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 1999;15:141-155.
17. Cohen J: Statistical Power Analysis for the Behavioral Sciences, ed 2. Hillsdale, Lawrence Erlbaum Associates, 1988.
18. Pickard AS, Johnson JA, Feeny DH: Responsiveness of generic health-related quality of life measures in stroke. Qual Life Res 2005;14:207-219.
19. Dolan P: Modeling valuations for EuroQoL health states. Med Care 1997;35:1095-1108.
20. Post PN, Stiggelbout AM, Wakker PP: The utility of health states after stroke: a systematic review of the literature. Stroke 2001;32:1425-1429.
21. Torrance GW, Feeny DH, Furlong WJ, Barr RD, Zhang Y, Wang Q: Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Med Care 1996;34:702-722.
22. Sneeuw KCA, Aaronson NK, de Haan RJ, Limburg M: Assessing quality of life after stroke. The value and limitations of proxy ratings. Stroke 1997;28:1541-1549.
23. Dorman PJ, Waddell F, Slattery J, Dennis M, Sandercock P: Are proxy assessments of health status after stroke with the EuroQol questionnaire feasible, accurate and unbiased? Stroke 1997;28:1883-1887.
24. Jönsson A-C, Lindgren I, Hallström B, Norrving B, Lindgren A: Determinants of quality of life in stroke survivors and their informal care givers. Stroke 2005;36:803-808.
25. Hackett ML, Duncan JR, Anderson CS, Broad JB, Bonita R: Health-related quality of life among long-term survivors of stroke: results from the Auckland Stroke Study, 1991-1992. Stroke 2000;31:440-447.